Health outcomes in economic evaluation: who should value health?
نویسنده
چکیده
The valuation of health states is an integral part of economic evaluation studies. The source of these valuations (general public vs. patients) is surrounded by controversy. Health state values generated by the general public are often different compared with those of patients. General public values may not account for adaptation of the patients; patients' values potentially incorporate self-interest. Decisions on the appropriate source of health values ultimately depend on the specific decision-making context and objectives of the evaluation. Differences in valuations and implications for decision-making should be explicitly addressed. Further research should systematically identify circumstances in which public and patients' valuations diverge. There appears ground for development of methods that allow the simultaneous incorporation of patients and public preferences. Existing literature which discusses the issues around the health state valuation is summarized.
منابع مشابه
Economic Evaluation of Infliximab for Treatment of Refractory Ulcerative Colitis in Iran: Cost-Effectiveness Analysis
The aim of this study is to assess cost-effectiveness of infliximab, compared with conventional treatments in patients with moderate to severe Ulcerative Colitis (UC) in Iran. We developed an analytical decision model with a 5-year-time horizon to follow up 1000 hypothetical patients, in order to estimate treatment costs and outcomes. Hypothetical patients, were individuals with moderate to sev...
متن کاملThe Need to Conduct Economic Evaluation Studies of Nursing Care in Iran
All health systems around the world are facing a lack of adequate financial resources to meet the health needs of their citizens. Health policymakers use economics and policy sciences to solve this problem and implement appropriate strategies for prioritizing and allocating limited resources to meet unlimited health needs. In this way, conducting Health Economic Evaluation studies to provide ev...
متن کاملClinical Endpoints and Economic Parameters for Market Access and Value Creation
On the contrary to limited and shrinking health care budgets, there is an ever increasing pressure on healthcare system providers for more and newer resource-oriented health care along with significant cost constraints. Therefore, one should not be surprised if an effective new therapy does not find its way in practice within publicly funded health care systems. The influence of any therapy on ...
متن کاملDiplomacy and Health: The End of the Utilitarian Era
Cost-effectiveness analysis (CEA), as a system of allocative efficiency for global health programs, is an influential criterion for resource allocation in the context of diplomacy and inherent foreign policy decisions therein. This is because such programs have diplomatic benefits and costs that can be uploaded from the recipient and affect the broader foreign policy interests of the donor and ...
متن کاملCost-effectiveness analysis alongside clinical trials II-An ISPOR Good Research Practices Task Force report.
Clinical trials evaluating medicines, medical devices, and procedures now commonly assess the economic value of these interventions. The growing number of prospective clinical/economic trials reflects both widespread interest in economic information for new technologies and the regulatory and reimbursement requirements of many countries that now consider evidence of economic value along with cl...
متن کاملTransforming Disciplinary Traditions; Comment on “Problems and Promises of Health Technologies: The Role of Early Health Economic Modeling”
Grutters et al show that economic assessments can inform the development of new health technologies at an early stage. This is an important contribution to health services and policy research, which implies a “shift away” from the more traditional forms of academic health economic modeling. Because transforming established disciplinary traditions is both valuable and de...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- British medical bulletin
دوره 97 شماره
صفحات -
تاریخ انتشار 2011